Home
About
Overview
Sharing Data
ORCID
Help
History (69)
Transcription Factor AP-2
Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.
Hamster refractoriness: the role of insensitivity of pineal target tissues.
Dementia with parkinsonism: Alzheimer’s disease is more common than dementia with Lewy bodies
The power and limitations of pharmacogenetic epidemiology.
See All 69 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The power and limitations of pharmacogenetic epidemiology.
Lapane K, Weinstock MA. The power and limitations of pharmacogenetic epidemiology. J Invest Dermatol. 2007 Aug; 127(8):1851-2.
View in:
PubMed
subject areas
Carcinoma, Squamous Cell
Clinical Trials as Topic
Glucocorticoids
Humans
Pharmacogenetics
Polymorphism, Genetic
Receptors, Glucocorticoid
Skin Neoplasms
authors with profiles
Kate L Lapane PhD